Skip to content
  • Debatforum
  • Seneste
  • Populære
  • Bruger
Temaer
  • Light
  • Dark

Kollaps
FORSIDEN
Log ind Opret konto

Genmab — Januar 2014

Planlagt Fastgjort Låst Flyttet Genmab
1.2k Indlæg 1 Posters 0 Visninger
  • Ældste til nyeste
  • Nyeste til ældste
  • Most Votes
Svar
  • Svar som emne
Login for at svare
Denne tråd er blevet slettet. Kun brugere med emne behandlings privilegier kan se den.
  • S Offline
    S Offline
    Sukkeralf
    wrote on sidst redigeret af
    #529

    Interessant og lad os håbe Genmab bliver blandt de første med IgA i klinikken - det ligger nok en del år ude i fremtiden, men fedt de er så innovative

    1 Reply Last reply
    0
    • S Offline
      S Offline
      Sukkeralf
      wrote on sidst redigeret af
      #530

      Link Preview Image
      Important Announcement

      favicon

      (www.biopharma-reporter.com)

      1 Reply Last reply
      0
      • nohopeN Offline
        nohopeN Offline
        nohope
        wrote on sidst redigeret af
        #531

        Er det her godt, men skidt for GEN aktionærer ? http://jyllands-posten.dk/aarhus/ECE4465078/ny-opdagelse-kan-sla-kraeft-ihjel/

        1 Reply Last reply
        0
        • investor1989I Offline
          investor1989I Offline
          investor1989
          wrote on sidst redigeret af
          #532

          Den danske opdagelse handler om at bekæmpe blærekræft, men gruppen har gjort lignende fund inden for tyktarmskræft.

          1 Reply Last reply
          0
          • investor1989I Offline
            investor1989I Offline
            investor1989
            wrote on sidst redigeret af
            #533

            man målretter - dvs. sprøjter direkte ind i canceren dvs. det lyder typisk som forsøg mod solid tumors. Så ikke konkurrent til andet end Humax-TF-ADC pt. Men nu er det jo meeeeeeeeeeeeega early og mange mange mange år ude i fremtiden selv hvis det giver succes i klinikken også

            1 Reply Last reply
            0
            • investor1989I Offline
              investor1989I Offline
              investor1989
              wrote on sidst redigeret af
              #534

              Det er mere positivt for Exiqon fordi det sætter fokus på RNA forskning som de sælger reagenser til.

              1 Reply Last reply
              0
              • SolsenS Offline
                SolsenS Offline
                Solsen
                wrote on sidst redigeret af
                #535

                Lyder det ikke mere til at være et "toxin" til ADC teknologien, det det skal ind i cancercellerne ?

                1 Reply Last reply
                0
                • 1 Offline
                  1 Offline
                  120281
                  wrote on sidst redigeret af
                  #536

                  Update fra J.P Morgan http://medwatch.dk/Medicinal___Biotek/article6413398.ece?utm_source=Feed&utm_medium=top&utm_campaign=Morgen&utm_content=2014-01-20+08%3A13%3A00

                  1 Reply Last reply
                  0
                  • 1 Offline
                    1 Offline
                    120281
                    wrote on sidst redigeret af
                    #537

                    Interessant: Kvalitetsjournalistik kræver investeringer. Del venligst denne artikel med andre ved at bruge nedenstående link. http://medwatch.dk/Medicinal___Biotek/article6413398.ece?utm_source=Feed&utm_medium=top&utm_campaign=Morgen&utm_content=2014-01-20+08%3A13%3A00#ixzz2qvZb9XlE
                    Kopier og videresend ikke artiklen. Det er i strid med ophavsretsloven og vores abonnementsbetingelser: http://medwatch.dk/service/betingelser

                    Samtidig mener Bruce Booth, at aktiviteterne og snakken på konferenc

                    1 Reply Last reply
                    0
                    • investor1989I Offline
                      investor1989I Offline
                      investor1989
                      wrote on sidst redigeret af
                      #538

                      Link Preview Image
                      JPM 2014: Broad Optimism About Biotech Innovation - LifeSciVC

                      The annual biotech pilgrimage to San Francisco has come to an end, and the upbeat, optimistic sentiment from #JPM14 bodes well as a barometer of the healthcare industry. Amidst the presentations and partying, there was lots of bullish thinking about

                      favicon

                      LifeSciVC (lifescivc.com)

                      1 Reply Last reply
                      0
                      • G Offline
                        G Offline
                        gentogen
                        wrote on sidst redigeret af
                        #539

                        Link Preview Image
                        PAGE NOT FOUND | J.P. Morgan

                        favicon

                        (www.jpmorgan.com)

                        1 Reply Last reply
                        0
                        • G Offline
                          G Offline
                          gentogen
                          wrote on sidst redigeret af
                          #540

                          In FY2013 (Oct 2012 to Sep 2013) 103 requests for breakthrough designation were
                          made with 32 requests granted and 62 denied

                          1 Reply Last reply
                          0
                          • G Offline
                            G Offline
                            gentogen
                            wrote on sidst redigeret af
                            #541

                            We continue to believe
                            that the biotech industry is in the early innings of an innovation cycle with many labelexpansion
                            opportunities and novel agents in phase 2 or 3 trials that are largely
                            unaccounted for in Street models. Hence, we are bullish on the group for 2014.

                            1 Reply Last reply
                            0
                            • 1 Offline
                              1 Offline
                              120281
                              wrote on sidst redigeret af
                              #542

                              Genmab måtte da gerne have været nævnt.

                              1 Reply Last reply
                              0
                              • 1 Offline
                                1 Offline
                                120281
                                wrote on sidst redigeret af
                                #543

                                Kan så se Janssen og GSK står på med Gen produkterne under BTD

                                1 Reply Last reply
                                0
                                • investor1989I Offline
                                  investor1989I Offline
                                  investor1989
                                  wrote on sidst redigeret af
                                  #544

                                  Genmab er den usynlige engine der skaber produkterne 🙂 de andre tager fame for dem

                                  1 Reply Last reply
                                  0
                                  • JørgenVarnæsJ Offline
                                    JørgenVarnæsJ Offline
                                    JørgenVarnæs
                                    wrote on sidst redigeret af
                                    #545

                                    næh - gode nyheder. Kempen hæver kursmål fra 200 til 285

                                    1 Reply Last reply
                                    0
                                    • 1 Offline
                                      1 Offline
                                      120281
                                      wrote on sidst redigeret af
                                      #546

                                      Ja men stadig overrasket over fordelingen på 10 analytikere hedder 4 køb, 2 neutral og 4 negative. Men dejligt med en mere der justere til små 300.

                                      1 Reply Last reply
                                      0
                                      • J Offline
                                        J Offline
                                        JKY_VH
                                        wrote on sidst redigeret af
                                        #547

                                        God morgen

                                        1 Reply Last reply
                                        0
                                        • R Offline
                                          R Offline
                                          Repsac
                                          wrote on sidst redigeret af
                                          #548

                                          Der er da heldigvis kommet lidt mere volumen i Gen i dag.

                                          1 Reply Last reply
                                          0

                                          Hello! It looks like you're interested in this conversation, but you don't have an account yet.

                                          Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.

                                          With your input, this post could be even better 💗

                                          Tilmeld Log ind

                                          • Log ind

                                          • Har du ikke en konto? Tilmeld

                                          • Login or register to search.
                                          • First post
                                            Last post
                                          0
                                          • Debatforum
                                          • Seneste
                                          • Populære
                                          • Bruger